These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 24159062)

  • 1. Activated protein C analog protects from ischemic stroke and extends the therapeutic window of tissue-type plasminogen activator in aged female mice and hypertensive rats.
    Wang Y; Zhao Z; Chow N; Rajput PS; Griffin JH; Lyden PD; Zlokovic BV
    Stroke; 2013 Dec; 44(12):3529-36. PubMed ID: 24159062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An activated protein C analog with reduced anticoagulant activity extends the therapeutic window of tissue plasminogen activator for ischemic stroke in rodents.
    Wang Y; Zhang Z; Chow N; Davis TP; Griffin JH; Chopp M; Zlokovic BV
    Stroke; 2012 Sep; 43(9):2444-9. PubMed ID: 22811462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activated protein C analog promotes neurogenesis and improves neurological outcome after focal ischemic stroke in mice via protease activated receptor 1.
    Wang Y; Zhao Z; Chow N; Ali T; Griffin JH; Zlokovic BV
    Brain Res; 2013 Apr; 1507():97-104. PubMed ID: 23438513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant treatment with neuroserpin increases the therapeutic window for tissue-type plasminogen activator administration in a rat model of embolic stroke.
    Zhang Z; Zhang L; Yepes M; Jiang Q; Li Q; Arniego P; Coleman TA; Lawrence DA; Chopp M
    Circulation; 2002 Aug; 106(6):740-5. PubMed ID: 12163437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Taurine Reduces tPA (Tissue-Type Plasminogen Activator)-Induced Hemorrhage and Microvascular Thrombosis After Embolic Stroke in Rat.
    Jin R; Xiao AY; Liu S; Wang M; Li G
    Stroke; 2018 Jul; 49(7):1708-1718. PubMed ID: 29844028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Final Results of the RHAPSODY Trial: A Multi-Center, Phase 2 Trial Using a Continual Reassessment Method to Determine the Safety and Tolerability of 3K3A-APC, A Recombinant Variant of Human Activated Protein C, in Combination with Tissue Plasminogen Activator, Mechanical Thrombectomy or both in Moderate to Severe Acute Ischemic Stroke.
    Lyden P; Pryor KE; Coffey CS; Cudkowicz M; Conwit R; Jadhav A; Sawyer RN; Claassen J; Adeoye O; Song S; Hannon P; Rost NS; Hinduja A; Torbey M; Lee JM; Benesch C; Rippee M; Rymer M; Froehler MT; Clarke Haley E; Johnson M; Yankey J; Magee K; Qidwai J; Levy H; Mark Haacke E; Fawaz M; Davis TP; Toga AW; Griffin JH; Zlokovic BV;
    Ann Neurol; 2019 Jan; 85(1):125-136. PubMed ID: 30450637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential neuroprotection and risk for bleeding from activated protein C with varying degrees of anticoagulant activity.
    Wang Y; Thiyagarajan M; Chow N; Singh I; Guo H; Davis TP; Zlokovic BV
    Stroke; 2009 May; 40(5):1864-9. PubMed ID: 19057019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole body hypothermia extends tissue plasminogen activator treatment window in the rat model of embolic stroke.
    Hassanipour M; Zarisfi M; Ehsani V; Allahtavakoli M
    Life Sci; 2020 Sep; 256():117450. PubMed ID: 32087233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurotoxicity of the anticoagulant-selective E149A-activated protein C variant after focal ischemic stroke in mice.
    Wang Y; Sinha RK; Mosnier LO; Griffin JH; Zlokovic BV
    Blood Cells Mol Dis; 2013 Aug; 51(2):104-8. PubMed ID: 23541526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic benefits of combined treatment with tissue plasminogen activator and 2-(4-methoxyphenyl)ethyl-2-acetamido-2-deoxy-β-d-pyranoside in an animal model of ischemic stroke.
    Yu S; Liu X; Shen Y; Xu H; Yang Y; Ding F
    Neuroscience; 2016 Jul; 327():44-52. PubMed ID: 27060484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PI3Kγ (Phosphoinositide 3-Kinase-γ) Inhibition Attenuates Tissue-Type Plasminogen Activator-Induced Brain Hemorrhage and Improves Microvascular Patency After Embolic Stroke.
    Jin R; Xiao AY; Li J; Wang M; Li G
    Hypertension; 2019 Jan; 73(1):206-216. PubMed ID: 30571560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-inflammatory, antithrombotic, and neuroprotective effects of activated protein C in a murine model of focal ischemic stroke.
    Shibata M; Kumar SR; Amar A; Fernandez JA; Hofman F; Griffin JH; Zlokovic BV
    Circulation; 2001 Apr; 103(13):1799-805. PubMed ID: 11282913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vepoloxamer Enhances Fibrinolysis of tPA (Tissue-Type Plasminogen Activator) on Acute Ischemic Stroke.
    Wang C; Huang R; Li C; Lu M; Emanuele M; Zhang ZG; Chopp M; Zhang L
    Stroke; 2019 Dec; 50(12):3600-3608. PubMed ID: 31587657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Species-dependent neuroprotection by activated protein C mutants with reduced anticoagulant activity.
    Guo H; Wang Y; Singh I; Liu D; Fernández JA; Griffin JH; Chow N; Zlokovic BV
    J Neurochem; 2009 Apr; 109(1):116-24. PubMed ID: 19166505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of tissue plasminogen activator timing on blood-brain barrier permeability and hemorrhagic transformation in rats with transient ischemic stroke.
    Zhang Y; Wang Y; Zuo Z; Wang Z; Roy J; Hou Q; Tong E; Hoffmann A; Sperberg E; Bredno J; Berr SS; Xie M; Lee K; Wintermark M
    J Neurol Sci; 2014 Dec; 347(1-2):148-54. PubMed ID: 25292413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extension of the thrombolytic time window with minocycline in experimental stroke.
    Murata Y; Rosell A; Scannevin RH; Rhodes KJ; Wang X; Lo EH
    Stroke; 2008 Dec; 39(12):3372-7. PubMed ID: 18927459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotective activities of activated protein C mutant with reduced anticoagulant activity.
    Guo H; Singh I; Wang Y; Deane R; Barrett T; Fernández JA; Chow N; Griffin JH; Zlokovic BV
    Eur J Neurosci; 2009 Mar; 29(6):1119-30. PubMed ID: 19302148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2016 Scientific Sessions Sol Sherry Distinguished Lecturer in Thrombosis: Thrombotic Stroke: Neuroprotective Therapy by Recombinant-Activated Protein C.
    Griffin JH; Mosnier LO; Fernández JA; Zlokovic BV
    Arterioscler Thromb Vasc Biol; 2016 Nov; 36(11):2143-2151. PubMed ID: 27758767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-Acetyl-Seryl-Aspartyl-Lysyl-Proline Augments Thrombolysis of tPA (Tissue-Type Plasminogen Activator) in Aged Rats After Stroke.
    Li C; Zhang L; Wang C; Teng H; Fan B; Chopp M; Zhang ZG
    Stroke; 2019 Sep; 50(9):2547-2554. PubMed ID: 31387512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety profile of the carotenoid trans sodium crocetinate administered to rabbits following multiple infarct ischemic strokes: a combination therapy study with tissue plasminogen activator.
    Lapchak PA
    Brain Res; 2010 Jan; 1309():136-45. PubMed ID: 19891959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.